Adherence and uptake of Francisella into host cells

Virulence

Volumn 4, Issue 8, 2013, Pages

  Brett Moreau, G ^a   Mann, Barbara J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Adherence; Attachment; Francisella tularensis; Internalization; LVS; Novicida

Indexed keywords

CAVEOLIN; COMPLEMENT RECEPTOR; CYTOCHALASIN D; ELONGATION FACTOR TU; FC RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOTEICHOIC ACID; MANNOSE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; OPSONIN; OUTER MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; SCAVENGER RECEPTOR; SURFACTANT PROTEIN A; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL LOAD; BACTERIUM ADHERENCE; ELECTRON MICROSCOPY; FRANCISELLA NOVICIDA; FRANCISELLA TULARENSIS; HOST CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPROMISED PATIENT; INTERNALIZATION; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; TULAREMIA;

BACTERIA (MICROORGANISMS); FRANCISELLA; FRANCISELLA TULARENSIS;

EID: 84888319814     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.25629     Document Type: Review

References (77)

1. Oyston PC, Sjostedt A, Titball RW. Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol 2004; 2:967-78; PMID:15550942; http://dx.doi.org/10.1038/nrmicro1045
2. Sjöstedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci 2007; 1105:1-29; PMID:17395726; http://dx.doi.org/10.1196/annals.1409.009
3. Forestal CA, Malik M, Catlett SV, Savitt AG, Benach JL, Sellati TJ, et al. Francisella tularensis has a significant extracellular phase in infected mice. J Infect Dis 2007; 196:134-7; PMID:17538893; http://dx.doi.org/10.1086/518611
4. Twine S, Byström M, Chen W, Forsman M, Golovliov I, Johansson A, et al. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect Immun 2005; 73:8345-52; PMID:16299332; http://dx.doi.org/10.1128/IAI.73.12.8345-8352.2005
5. Qin A, Scott DW, Thompson JA, Mann BJ. Identification of an essential Francisella tularensis subsp. tularensis virulence factor. Infect Immun 2009; 77:152-61; PMID:18981253; http://dx.doi.org/10.1128/IAI.01113-08
6. Bröms JE, Meyer L, Lavander M, Larsson P, Sjöstedt A. DotU and VgrG, core components of type VI secretion systems, are essential for Francisella LVS pathogenicity. PLoS One 2012; 7:e34639; PMID:22514651; http://dx.doi.org/10.1371/journal.pone.0034639
7. Schwartz JT, Barker JH, Long ME, Kaufman J, McCracken J, Allen LA. Natural IgM mediates complement-dependent uptake of Francisella tularensis by human neutrophils via complement receptors 1 and 3 in nonimmune serum. J Immunol 2012; 189:3064-77; PMID:22888138; http://dx.doi.org/10.4049/jimmunol.1200816
8. Ben Nasr A, Haithcoat J, Masterson JE, Gunn JS, Eaves-Pyles T, Klimpel GR. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria. J Leukoc Biol 2006; 80:774-86; PMID:16857732; http://dx.doi.org/10.1189/jlb.1205755
9. Lai XH, Golovliov I, Sjöstedt A. Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect Immun 2001; 69:4691-4; PMID:11402018; http://dx.doi.org/10.1128/IAI.69.7.4691-4694.2001
10. Telepnev M, Golovliov I, Sjöstedt A. Francisella tularensis LVS initially activates but subsequently down-regulates intracellular signaling and cytokine secretion in mouse monocytic and human peripheral blood mononuclear cells. Microb Pathog 2005; 38:239-47; PMID:15925273; http://dx.doi.org/10.1016/j.mic-path.2005.02.003
11. Lai XH, Shirley RL, Crosa L, Kanistanon D, Tempel R, Ernst RK, et al. Mutations of Francisella novicida that alter the mechanism of its phagocytosis by murine macrophages. PLoS One 2010; 5:e11857; PMID:20686600; http://dx.doi.org/10.1371/journal. pone.0011857
12. Tamilselvam B, Daefler S. Francisella targets cholesterol-rich host cell membrane domains for entry into macrophages. J Immunol 2008; 180:8262-71; PMID:18523292
13. Jayakar HR, Parvathareddy J, Fitzpatrick EA, Bina XR, Bina JE, Re F, et al. A galU mutant of Francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia. BMC Microbiol 2011; 11:179; PMID:21819572; http://dx.doi.org/10.1186/1471-2180-11-179
14. Peng K, Broz P, Jones J, Joubert LM, Monack D. Elevated AIM2-mediated pyroptosis triggered by hypercytotoxic Francisella mutant strains is attributed to increased intracellular bacteriolysis. Cell Microbiol 2011; 13:1586-600; PMID:21883803; http://dx.doi.org/10.1111/j.1462-5822.2011.01643.x
15. Barel M, Hovanessian AG, Meibom K, Briand JP, Dupuis M, Charbit A. A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu. BMC Microbiol 2008; 8:145; PMID:18789156; http://dx.doi.org/10.1186/1471-2180-8-145
16. Craven RR, Hall JD, Fuller JR, Taft-Benz S, Kawula TH. Francisella tularensis invasion of lung epithelial cells. Infect Immun 2008; 76:2833-42; PMID:18426871; http://dx.doi.org/10.1128/IAI.00043-08
17. Melillo A, Sledjeski DD, Lipski S, Wooten RM, Basrur V, Lafontaine ER. Identification of a Francisella tularensis LVS outer membrane protein that confers adherence to A549 human lung cells. FEMS Microbiol Lett 2006; 263:102-8; PMID:16958857; http://dx.doi.org/10.1111/j.1574-6968.2006.00413.x
18. Bradburne CE, Verhoeven AB, Manyam GC, Chaudhry SA, Chang EL, Thach DC, et al. Temporal transcriptional response during infection of type II alveolar epithelial cells with Francisella tularensis live vaccine strain (LVS) supports a general host suppression and bacterial uptake by macropinocytosis. J Biol Chem 2013; 288:10780-91; PMID:23322778; http://dx.doi.org/10.1074/jbc.M112.362178
19. Law HT, Lin AE, Kim Y, Quach B, Nano FE, Guttman JA. Francisella tularensis uses cholesterol and clathrin based endocytic mechanisms to invade hepatocytes. Sci Rep 2011; 1:192; PMID:22355707; http://dx.doi.org/10.1038/srep00192
20. Horzempa J, O'Dee DM, Shanks RM, Nau GJ. Francisella tularensis DeltapyrF mutants show that replication in nonmacrophages is sufficient for pathogenesis in vivo. Infect Immun 2010; 78:2607-19; PMID:20385757; http://dx.doi.org/10.1128/IAI.00134-10
21. Schulert GS, Allen LA. Differential infection of mononuclear phagocytes by Francisella tularensis: role of the macrophage mannose receptor. J Leukoc Biol 2006; 80:563-71; PMID:16816147; http://dx.doi.org/10.1189/jlb.0306219
22. Balagopal A, MacFarlane AS, Mohapatra N, Soni S, Gunn JS, Schlesinger LS. Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect Immun 2006; 74:5114-25; PMID:16926403; http://dx.doi.org/10.1128/IAI.00795-06
23. Lindemann SR, McLendon MK, Apicella MA, Jones BD. An in vitro model system used to study adherence and invasion of Francisella tularensis live vaccine strain in nonphagocytic cells. Infect Immun 2007; 75:3178-82; PMID:17339345; http://dx.doi.org/10.1128/IAI.01811-06
24. Lo KY, Chua MD, Abdulla S, Law HT, Guttman JA. Examination of in vitro epithelial cell lines as models for Francisella tularensis non-phagocytic infections. J Microbiol Methods 2013; 93:153-60; PMID:23523968; http://dx.doi.org/10.1016/j. mimet.2013.03.004
25. Horzempa J, O'Dee DM, Stolz DB, Franks JM, Clay D, Nau GJ. Invasion of erythrocytes by Francisella tularensis. J Infect Dis 2011; 204:51-9; PMID:21628658; http://dx.doi.org/10.1093/infdis/jir221
26. Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, et al. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect Immun 2008; 76:5843-52; PMID:18852251; http://dx.doi.org/10.1128/IAI.01176-08
27. Vonkavaara M, Telepnev MV, Rydén P, Sjöstedt A, Stöven S. Drosophila melanogaster as a model for elucidating the pathogenicity of Francisella tularensis. Cell Microbiol 2008; 10:1327-38; PMID:18248629; http://dx.doi.org/10.1111/j.1462-5822.2008.01129.x
28. Santic M, Akimana C, Asare R, Kouokam JC, Atay S, Kwaik YA. Intracellular fate of Francisella tularensis within arthropod-derived cells. Environ Microbiol 2009; 11:1473-81; PMID:19220402; http://dx.doi.org/10.1111/j.1462-2920.2009.01875.x
29. Ahlund MK, Rydén P, Sjöstedt A, Stöven S. Directed screen of Francisella novicida virulence determinants using Drosophila melanogaster. Infect Immun 2010; 78:3118-28; PMID:20479082; http://dx.doi.org/10.1128/IAI.00146-10
30. Moule MG, Monack DM, Schneider DS. Reciprocal analysis of Francisella novicida infections of a Drosophila melanogaster model reveal host-pathogen conflicts mediated by reactive oxygen and imd-regulated innate immune response. PLoS Pathog 2010; 6:e1001065; PMID:20865166; http://dx.doi.org/10.1371/journal. ppat.1001065
31. Abd H, Johansson T, Golovliov I, Sandström G, Forsman M. Survival and growth of Francisella tularensis in Acanthamoeba castellanii. Appl Environ Microbiol 2003; 69:600-6; PMID:12514047; http://dx.doi.org/10.1128/AEM.69.1.600-606.2003
32. El-Etr SH, Margolis JJ, Monack D, Robison RA, Cohen M, Moore E, et al. Francisella tularensis type A strains cause the rapid encystment of Acanthamoeba castellanii and survive in amoebal cysts for three weeks postinfection. Appl Environ Microbiol 2009; 75:7488-500; PMID:19820161; http://dx.doi.org/10.1128/AEM.01829-09
33. Santic M, Ozanic M, Semic V, Pavokovic G, Mrvcic V, Kwaik YA. Intra-Vacuolar Proliferation of F. novicida within H. vermiformis. Front Microbiol 2011; 2:78; PMID:21747796; http://dx.doi.org/10.3389/fmicb.2011.00078
34. Tønjum T, Koomey M. The pilus colonization factor of pathogenic neisserial species: organelle biogenesis and structure/function relationships--a review. Gene 1997; 192:155-63; PMID:9224886; http://dx.doi.org/10.1016/S0378-1119(97)00018-8
35. Mattick JS. Type IV pili and twitching motility. Annu Rev Microbiol 2002; 56:289-314; PMID:12142488; http://dx.doi.org/10.1146/annurev. micro.56.012302.160938
36. Salomonsson EN, Forslund AL, Forsberg A. Type IV Pili in Francisella-A Virulence Trait in an Intracellular Pathogen. Front Microbiol 2011; 2:29; PMID:21687421; http://dx.doi.org/10.3389/fmicb.2011.00029
37. Gil H, Benach JL, Thanassi DG. Presence of pili on the surface of Francisella tularensis. Infect Immun 2004; 72:3042-7; PMID:15102818; http://dx.doi.org/10.1128/IAI.72.5.3042-3047.2004
38. Zogaj X, Chakraborty S, Liu J, Thanassi DG, Klose KE. Characterization of the Francisella tularensis subsp. novicida type IV pilus. Microbiology 2008; 154:2139-50; PMID:18599841; http://dx.doi.org/10.1099/mic.0.2008/018077-0
39. Ark NM, Mann BJ. Impact of Francisella tularensis pilin homologs on pilus formation and virulence. Microb Pathog 2011; 51:110-20; PMID:21605655; http://dx.doi.org/10.1016/j.micpath.2011.05.001
40. Chakraborty S, Monfett M, Maier TM, Benach JL, Frank DW, Thanassi DG. Type IV pili in Francisella tularensis: roles of pilF and pilT in fiber assembly, host cell adherence, and virulence. Infect Immun 2008; 76:2852-61; PMID:18426883; http://dx.doi.org/10.1128/IAI.01726-07
41. Forslund AL, Kuoppa K, Svensson K, Salomonsson E, Johansson A, Byström M, et al. Direct repeat mediated deletion of a type IV pilin gene results in major virulence attenuation of Francisella tularensis. Mol Microbiol 2006; 59:1818-30; PMID:16553886; http://dx.doi.org/10.1111/j.1365-2958.2006.05061.x
42. Zarrella TM, Singh A, Bitsaktsis C, Rahman T, Sahay B, Feustel PJ, et al. Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS One 2011; 6:e22335; PMID:21799828; http://dx.doi.org/10.1371/journal.pone.0022335
43. Twine SM, Mykytczuk NC, Petit MD, Shen H, Sjöstedt A, Wayne Conlan J, et al. In vivo proteomic analysis of the intracellular bacterial pathogen, Francisella tularensis, isolated from mouse spleen. Biochem Biophys Res Commun 2006; 345:1621-33; PMID:16730660; http://dx.doi.org/10.1016/j.bbrc.2006.05.070
44. Wehbi H, Portillo E, Harvey H, Shimkoff AE, Scheurwater EM, Howell PL, et al. The peptidoglycan-binding protein FimV promotes assembly of the Pseudomonas aeruginosa type IV pilus secretin. J Bacteriol 2011; 193:540-50; PMID:21097635; http://dx.doi.org/10.1128/JB.01048-10
45. Buist G, Steen A, Kok J, Kuipers OP. LysM, a widely distributed protein motif for binding to (peptido)glycans. Mol Microbiol 2008; 68:838-47; PMID:18430080; http://dx.doi.org/10.1111/j.1365-2958.2008.06211.x
46. Granato D, Bergonzelli GE, Pridmore RD, Marvin L, Rouvet M, Corthésy-Theulaz IE. Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins. Infect Immun 2004; 72:2160-9; PMID:15039339; http://dx.doi.org/10.1128/IAI.72.4.2160-2169.2004
47. Kunert A, Losse J, Gruszin C, Hühn M, Kaendler K, Mikkat S, et al. Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J Immunol 2007; 179:2979-88; PMID:17709513
48. Balasubramanian S, Kannan TR, Baseman JB. The surface-exposed carboxyl region of Mycoplasma pneumoniae elongation factor Tu interacts with fibronectin. Infect Immun 2008; 76:3116-23; PMID:18411296; http://dx.doi.org/10.1128/IAI.00173-08
49. Pierini LM. Uptake of serum-opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors. Cell Microbiol 2006; 8:1361-70; PMID:16882038; http://dx.doi.org/10.1111/j.1462-5822.2006.00719.x
50. Geier H, Celli J. Phagocytic receptors dictate phagosomal escape and intracellular proliferation of Francisella tularensis. Infect Immun 2011; 79:2204-14; PMID:21422184; http://dx.doi.org/10.1128/IAI.01382-10
51. Clay CD, Soni S, Gunn JS, Schlesinger LS. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J Immunol 2008; 181:5568-78; PMID:18832715
52. Ben Nasr A, Klimpel GR. Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis. J Leukoc Biol 2008; 84:77-85; PMID:18430786; http://dx.doi.org/10.1189/jlb.0807526
53. Geier H, Celli J. Phagocytic receptors dictate phagosomal escape and intracellular proliferation of Francisella tularensis. Infect Immun 2011; 79:2204-14; PMID:21422184; http://dx.doi.org/10.1128/IAI.01382-10
54. Peiser L, Gough PJ, Kodama T, Gordon S. Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect Immun 2000; 68:1953-63; PMID:10722588; http://dx.doi.org/10.1128/IAI.68.4.1953-1963.2000
55. Dunne DW, Resnick D, Greenberg J, Krieger M, Joiner KA. The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc Natl Acad Sci U S A 1994; 91:1863-7; PMID:8127896; http://dx.doi.org/10.1073/pnas.91.5.1863
56. Wright SD, Silverstein SC. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J Exp Med 1983; 158:2016-23; PMID:6227677; http://dx.doi.org/10.1084/jem.158.6.2016
57. Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol 2002; 20:825-52; PMID:11861619; http://dx.doi.org/10.1146/annurev.immunol.20.103001.114744
58. Leander R, Dai S, Schlesinger LS, Friedman A. A mathematical model of CR3/TLR2 crosstalk in the context of Francisella tularensis infection. PLoS Comput Biol 2012; 8:e1002757; PMID:23133361; http://dx.doi.org/10.1371/journal.pcbi.1002757
59. Dai S, Rajaram MV, Curry HM, Leander R, Schlesinger LS. Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. PLoS Pathog 2013; 9:e1003114; PMID:23359218; http://dx.doi.org/10.1371/journal.ppat.1003114
60. Clemens DL, Horwitz MA. Uptake and intracellular fate of Francisella tularensis in human macrophages. Ann N Y Acad Sci 2007; 1105:160-86; PMID:17435118; http://dx.doi.org/10.1196/annals.1409.001
61. Parsa KV, Butchar JP, Rajaram MV, Cremer TJ, Tridandapani S. The tyrosine kinase Syk promotes phagocytosis of Francisella through the activation of Erk. Mol Immunol 2008; 45:3012-21; PMID:18295889; http://dx.doi.org/10.1016/j.molimm.2008.01.011
62. Clemens DL, Lee BY, Horwitz MA. Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect Immun 2005; 73:5892-902; PMID:16113308; http://dx.doi.org/10.1128/IAI.73.9.5892-5902.2005
63. Clemens DL, Lee BY, Horwitz MA. O-antigen deficient Francisella tularensis Live Vaccine Strain mutants are ingested via an aberrant form of looping phagocytosis and show altered kinetics of intracellular trafficking in human macrophages. Infect Immun 2012; 80:952-67; PMID:22202123; http://dx.doi.org/10.1128/IAI.05221-11
64. Bohdanowicz M, Grinstein S. Role of phospholipids in endocytosis, phagocytosis, and macropinocytosis. Physiol Rev 2013; 93:69-106; PMID:23303906; http://dx.doi.org/10.1152/physrev.00002.2012
65. Mercer J, Helenius A. Gulping rather than sipping: macropinocytosis as a way of virus entry. Curr Opin Microbiol 2012; 15:490-9; PMID:22749376; http://dx.doi.org/10.1016/j.mib.2012.05.016
66. West MA, Antoniou AN, Prescott AR, Azuma T, Kwiatkowski DJ, Watts C. Membrane ruffling, macropinocytosis and antigen presentation in the absence of gelsolin in murine dendritic cells. Eur J Immunol 1999; 29:3450-5; PMID:10556799; http://dx.doi.org/10.1002/(SICI)1521-4141(199911)29:113.0.CO;2-A
67. Lafont F, van der Goot FG. Bacterial invasion via lipid rafts. Cell Microbiol 2005; 7:613-20; PMID:15839890; http://dx.doi.org/10.1111/j.1462-5822.2005.00515.x
68. Vieira FS, Corrêa G, Einicker-Lamas M, Coutinho-Silva R. Host-cell lipid rafts: a safe door for micro-organisms? Biol Cell 2010; 102:391-407; PMID:20377525; http://dx.doi.org/10.1042/BC20090138
69. Parton RG, Richards AA. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic 2003; 4:724-38; PMID:14617356; http://dx.doi.org/10.1034/j.1600-0854.2003.00128.x
70. Singh A, Rahman T, Malik M, Hickey AJ, Leifer CA, Hazlett KR, et al. Discordant results obtained with Francisella tularensis during in vitro and in vivo immunological studies are attributable to compromised bacterial structural integrity. PLoS One 2013; 8:e58513; PMID:23554897; http://dx.doi.org/10.1371/journal.pone.0058513
71. Kannan S, Audet A, Knittel J, Mullegama S, Gao GF, Wu M. Src kinase Lyn is crucial for Pseudomonas aeruginosa internalization into lung cells. Eur J Immunol 2006; 36:1739-52; PMID:16791881; http://dx.doi.org/10.1002/eji.200635973
72. Keck S, Freudenberg M, Huber M. Activation of murine macrophages via TLR2 and TLR4 is negatively regulated by a Lyn/PI3K module and promoted by SHIP1. J Immunol 2010; 184:5809-18; PMID:20385881; http://dx.doi.org/10.4049/jimmu-nol.0901423
73. Cole LE, Elkins KL, Michalek SM, Qureshi N, Eaton LJ, Rallabhandi P, et al. Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity. J Immunol 2006; 176:6888-99; PMID:16709849
74. Cole LE, Shirey KA, Barry E, Santiago A, Rallabhandi P, Elkins KL, et al. Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages. Infect Immun 2007; 75:4127-37; PMID:17517865; http://dx.doi.org/10.1128/IAI.01868-06
75. Hajjar AM, Harvey MD, Shaffer SA, Goodlett DR, Sjöstedt A, Edebro H, et al. Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect Immun 2006; 74:6730-8; PMID:16982824; http://dx.doi.org/10.1128/IAI.00934-06
76. Li H, Nookala S, Bina XR, Bina JE, Re F. Innate immune response to Francisella tularensis is mediated by TLR2 and caspase-1 activation. J Leukoc Biol 2006; 80:766-73; PMID:16895974; http://dx.doi.org/10.1189/jlb.0406294
77. Medina EA, Morris IR, Berton MT. Phosphatidylinositol 3-kinase activation attenuates the TLR2-mediated macrophage proinflammatory cytokine response to Francisella tularensis live vaccine strain. J Immunol 2010; 185:7562-72; PMID:21098227; http://dx.doi.org/10.4049/jimmunol.0903790